| ORNBV Stock | | | EUR 45.35 0.28 0.61% |
Chairman
Mr. Timo Lappalainen has served as President, Chief Executive Officer and Chairman of the Executive Management Board of Orion Oyj since January 1, 2008. He joined Orion in 1999 as Senior Vice President, Business Development and later on moved to the position of Executive Vice President, Orion Pharma . In 2005, he was appointed Senior Vice President, Proprietary Products and Animal Health, and held the position until 2007. Prior to joining Orion, he worked as Vice President, International Marketing and Business Development at Leiras Oy Vice President, Business Development and General Manager of Finvest German unit at Finvest Ltd., and Consultant at Arthur Andersen Co., Chicago, the United States . He is Member of the Board of Kemira Oyj since 2014, Chemical Industry Federation of Finland since 2008, Finnish Foundation for Cardiovascular Research since 2010, The Research Institute of the Finnish Economy ETLA since 2017 and The Finnish Business and Policy Forum EVA since 2017, as well as Member of the Supervisory Board of The Finnish Fair Corporation since 2009. In addition, he is a member of the Council of the Helsinki Region Chamber of Commerce. He was Chairman of the Board of Chemical Industry Federation of Finland, Vice Chairman of the Board of Chemical Industry Federation of Finland, Member of the Board of Confederation of Finnish Industries, EK, Vaisala Oyj and ICC Finland . He holds MS degree in Engineering. since 2008.
| Age | 61 |
| Tenure | 16 years |
| Phone | 358 10 4261 |
| Web | https://www.orion.fi |
Lappalainen was Vice Chairman of the Board of Directors of Chemical Industry Federation of Finland since 2017. He is also Member of the Board of Kemira Oyj since 2014, Chemical Industry Federation of Finland since 2008, Finnish Foundation for Cardiovascular Research since 2010, The Research Institute of the Finnish Economy ETLA since 2017 and The Finnish Business and Policy Forum EVA since 2017, as well as Member of the Supervisory Board of The Finnish Fair Corporationration since 2009. In addition, he is a member of the Council of the Helsinki Region Chamber of Commerce. He was Chairman of the Board of Chemical Industry Federation of Finland, Vice Chairman of the Board of Chemical Industry Federation of Finland, Member of the Board of Confederation of Finnish Industries, EK, Vaisala Oyj and ICC Finland . He holds MS degree in Engineering.
Orion Oyj Management Efficiency
The company has return on total asset
(ROA) of
0.2077 % which means that it generated a profit of $0.2077 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.4065 %, meaning that it generated $0.4065 on every $100 dollars invested by stockholders. Orion Oyj's management efficiency ratios could be used to measure how well Orion Oyj manages its routine affairs as well as how well it operates its assets and liabilities.
Orion Oyj B has accumulated 100
M in total debt with debt to equity ratio
(D/E) of 5.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Orion Oyj B has a current ratio of 2.41, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Orion Oyj until it has trouble settling it off, either with new capital or with free cash flow. So, Orion Oyj's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Orion Oyj B sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Orion to invest in growth at high rates of return. When we think about Orion Oyj's use of debt, we should always consider it together with cash and equity.
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients , and diagnostic tests worldwide. The company was founded in 1917 and is headquartered in Espoo, Finland. Orion B operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 3352 people. Orion Oyj B (ORNBV) is traded on Helsinki Exchange in Finland and employs 3,500 people.
Management Performance
Orion Oyj B Leadership Team
Elected by the shareholders, the Orion Oyj's board of directors comprises two types of representatives: Orion Oyj inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orion. The board's role is to monitor Orion Oyj's management team and ensure that shareholders' interests are well served. Orion Oyj's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orion Oyj's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Terhi Ormio, VP Communications | |
| Liisa Hurme, Senior Vice President Specialty Products and Chairman of the Board of Fermion Oy; Member of the Executive Management Board | |
| MBA M, Sr Board | |
| Juhani Kankaanpaa, Sr Board | |
| Olli LlM, Gen Functions | |
| Tuukka MSc, Investor Officer | |
| Timo Lappalainen, President CEO, Chairman of the Executive Management Board | |
| Pr MD, Sr Board | |
| MSc MSc, Sr Board | |
Orion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orion Oyj a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Orion Stock
Orion Oyj financial ratios help investors to determine whether Orion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Orion with respect to the benefits of owning Orion Oyj security.